Navigation Links
2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion

mpounds in research and discovery. Antisense Pharma has been honored with the Bavarian Innovation Award and the German Founders Award.

This document contains forward-looking statements with respect to the future business of Antisense Pharma GmbH. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that could occur in the future. There is a number of factors that could cause actual results and developments to differ materially. Antisense Pharma GmbH disclaims any intent of obligation to update any of these forward-looking statements.


'"/>




Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
5. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
6. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
7. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
8. MaxCyte and Medinet to Present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia
9. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
10. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
11. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting

Post Your Comments:
(Date:12/1/2009)... , , LANSING, Mich., Dec. 1 /PRNewswire-Fi...nounced today that it has acquired the BioKits foo...robe Incorporated ( GPRO). The acquisition include...and fish speciation, and plant genetics. ,, Gen...cquisition of Tepnel Life Sciences plc in April 20...
(Date:12/1/2009)... , , ARLINGTON, Va., Dec. 1 /PRNewswi...f its newest report, The Market Outlook for Rese... appropriated to the NIH Scientific Research progr...ARRA) is being earmarked for lab renovations, Chal...nd research that spans multiple public and non-pro...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire-First...leading source of health information, today announ...wards. The fourth annual WebMD Health Heroes honor...courage and perseverance, who lead an effort to he... http://www.newscom.com/cgi-bin/prnh/20091201/NY...
Breaking Medicine Technology:Neogen Acquires Gen-Probe's BioKits Food Safety Business 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3Aprima and MRM Partner to Bring Award Winning Electronic Health Record Solution to Practices in Tennessee Virginia 59337 1Aprima and MRM Partner to Bring Award Winning Electronic Health Record Solution to Practices in Tennessee Virginia 59337 2Aprima and MRM Partner to Bring Award Winning Electronic Health Record Solution to Practices in Tennessee Virginia 59337 3Humidifiers Not Just for Children Anymore AchooAllergy com Announces All New Humidifiers Offering 59335 1Humidifiers Not Just for Children Anymore AchooAllergy com Announces All New Humidifiers Offering 59335 2Humidifiers Not Just for Children Anymore AchooAllergy com Announces All New Humidifiers Offering 59335 3ADSC 26apos 3Bs Pain Management Reinforcement 59333 1ADSC 26apos 3Bs Pain Management Reinforcement 59333 2
...ifornia, June 4 BN,ImmunoTherapeutics, Inc. has i...apeutic vaccine candidate against prostate cancer....8 male patients with,non-metastatic as well as hor...nt in the US. Secondary objectives of the trial in...ce prostate antigen-specific immune,responses, as ...
... of the Dana-Farber Cancer Institute presents phas...al activity of perifosine in patients with relap...NEW YORK, June 3 Keryx Biopharmaceuticals,Inc. (N...s of perifosine,(KRX-0401) in patients with relaps...was presented at the 44th Annual Meeting of the,Am...
Other Medicine Technology:BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine 2Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 4Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 5Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 6
(Date:12/1/2009)... WASHINGTON, Dec. 1 The... clinic in Los Angeles, has agreed to pay the Unit... received illegal kickbacks from HealthSouth Corpo... ,, The settlement resolves allegations that ...orm of stock option grants, donations to the Kerla...
(Date:12/1/2009)...ccreta is increasingly common but more easily iden...(HealthDay News) -- A magnetic resonance imaging ...tening pregnancy complication called placenta accr... when the placenta surrounding a fetus attaches to... placenta can pull out parts of the uterine wall, ...
(Date:12/1/2009)..., WASHINGTON, Dec. 1 Wi... a growing number of employers are providing self-...en enrollment season, according to a new survey by... majority of employers who offer these tools belie...an decisions. ,, According to the survey, 45 pe...
(Date:12/1/2009)..., BELLEVUE, Wash., Dec 1 Edifec...hcare Channel Modernization solutions announced an...at facilitates HIPAA 4010A1 to HIPAA 5010 migratio...0A1-5010 conversion maps, allows generation of tes...0A1 and 5010 in production, thus addressing most r...
(Date:12/1/2009)...ests that ,less affirming, isolating behaviors ju...c. 1 (HealthDay News) -- A new study suggests that...ence others to feel lonely, too. , "Loneliness ...o three degrees of separation," said James H. Fowl...er issue of the Journal of Personality and Social...
Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Serious Pregnancy Complication Detected With MRI 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3
...U.S. Food and Drug Administration (FDA) today appr...m tartrate) immediate-release tablets.// Zolpidem ... indicated for the short-term treatment of insomni...nd regulatory process," said Gary J. Buehler, dire...
...chocolate giants Cadbury have to pay heavily for t...he company had failed to inform the concerned auth...traces of bacteria in the samples of chocolates at...Regulations 2004. The Birmingham City Council...
...nternational meeting organized to thrash out issue...valuable //opportunity to focus attention on a bur...al communities. Amongst the Inuit population of Nu...rowned upon for their lack of attention on child i...
...r causing bugs may not be all that bad for you. Re...Helicobacter pylori to reduced chances of developi...ew York University School of Medicine, who publish... about asthma and allergy history. This involved a...
...archers from have found that infection with HIV, t... increased risk of myocardial infarction or heart ...sk factors were also increased in study participan... a higher incidence of myocardial infarction and m...
... deficiency anemia is the commonest medical disord...fetal health.// Despite several national programme...ng pregnancy, the success has not been as anticipa...Girls born underweight are at risk of producing sm...
Other Medicine News:Health News:FDA Approves First Generic Versions of Ambien for Insomnia 2Health News:Cadbury Indicted on Salmonella Scare 2Health News:Suicide - Aboriginal Communities Take Stock of the Killing Numbers 2Health News:Ulcer Causing Microbe Linked To Protection From Asthma 2Health News:HIV Infection Associated With Increased Risk of Heart Attack 2
COCOONReusableLower Torso
Model 522 - Upper Body Blanket
CritiCool™
...he OPMI VISU 210, Carl Zeiss has created a surgica...e state-of-the-art for ophthalmic surgery. Its wid...urgeons and it offers new functions to improve dep...pletely integrated assistant's microscope the OPMI...
Medicine Products: